| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben Monate. | 263 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit - mit einem internationalem Nikotinpartner um sieben... ► Artikel lesen | |
| Di | Rapid Dose Therapeutics Corp: Rapid Dose extends precommercialization nicotine deal | 2 | Stockwatch | ||
| Mo | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner | 300 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 20, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company developing innovative drug delivery solutions... ► Artikel lesen | |
| 03.10. | Rapid Dose Therapeutics Corp: Rapid Dose pays debt interest with 592,533 shares | 1 | Stockwatch | ||
| 02.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 373 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 04.08. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Submits QuickStrip Nicotine Product for Health Canada Approval | 396 | Newsfile | Burlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company focused on innovative drug delivery technologies... ► Artikel lesen | |
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 29.07. | Rapid Dose Therapeutics Corp: Rapid Dose, Eco work on harm reduction pilot project | 2 | Stockwatch | ||
| 29.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics and Eco Canadian Organic Inc. Initiate Health Canada Funded SUAP Harm Reduction Pilot Project on First Nations Using QuickStrip to Combat Opiate Addiction Crisis | 188 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 29, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is proud to announce the launch of a new... ► Artikel lesen | |
| 22.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: QuickStrip Technology - How Rapid Dose Is Changing The Way We Take Medicine | 576 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 04.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares as fee payments to directors | 1 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics issues shares for interest | 2 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 618 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 513 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 02.07. | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Rapid Dose's Drug Delivery Tech in NFL-Funded Study | 317 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 2, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded... ► Artikel lesen | |
| 03.06. | Rapid Dose Therapeutics Corp: Rapid Dose closes debt settlement, issues 1.88M shares | 2 | Stockwatch | ||
| 02.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Completion of Share Issuance in Debt Settlement with Creditors | 373 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 10, 2025, it has... ► Artikel lesen | |
| 28.05. | PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller | 326 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Partnerschaft mit weltweit führendem Tabakhersteller
Unternehmensmitteilung für den Kapitalmarkt
Rapid Dose Therapeutics Inc.: Partnerschaft mit... ► Artikel lesen | |
| 28.05. | Rapid Dose Therapeutics Corp.: Partnerschaft mit weltweit führendem Tabakhersteller | 476 | IR-WORLD | BURLINGTON, ON - 26. Mai 2025 - Rapid Dose Therapeutics Corp. ("RDT" oder das "Unternehmen") (CSE: DOSE), ein kanadisches Biowissenschaftsunternehmen, das sich
auf innovative Lösungen für die... ► Artikel lesen | |
| 28.05. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $3-million private placement | 3 | Stockwatch | ||
| 27.05. | Rapid Dose Therapeutics announces proposed equity private placement financing of up to $3M | 2 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 90,95 | +0,17 % | BioNTech startet milliardenschweres Umtauschangebot für CureVac-Aktien | BioNTech hat das öffentliche Umtauschangebot für alle ausstehenden Aktien von CureVac N.V. gestartet. Das Angebot basiert auf dem Kaufvertrag vom 12. Juni 2025 und sieht vor, dass jede CureVac-Aktie... ► Artikel lesen | |
| CORE ONE LABS | 0,079 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,502 | -4,56 % | Biotech-Investoren sollten diese Zulieferer kennen: Thermo Fisher Scientific, BioNxt, AptarGroup | Während neue Medikamente die Schlagzeilen dominieren, sind es oft Zulieferer und Serviceanbieter, die langfristig solide Renditen liefern. Drei Beispiele: Thermo Fisher Scientific, BioNxt Solutions... ► Artikel lesen | |
| CLINUVEL | 6,475 | +0,78 % | Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy | Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
30.09.2025 / 10:52 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The... ► Artikel lesen | |
| AMYRIS | - | - | Amyris gains sole control of Brazilian fermentation facility | ||
| ATAI LIFE SCIENCES | 5,050 | +1,88 % | Analyst Expectations For ATAI Life Sciences' Future | ||
| VIDAC PHARMA | 0,520 | -0,38 % | PTA-Adhoc: Vidac Pharma Holding PLC: Geplanter Antrag auf Einbeziehung in den Freiverkehr der Börse Düsseldorf (Teilbereich Primärmarkt) | DJ PTA-Adhoc: Vidac Pharma Holding PLC: Geplanter Antrag auf Einbeziehung in den Freiverkehr der Börse Düsseldorf (Teilbereich Primärmarkt)
Veröffentlichung von Insiderinformationen gemäß Artikel... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,026 | +9,13 % | SOL Global Investments Corp.: SOL Global Announces Change of Auditor | Toronto, Ontario--(Newsfile Corp. - October 15, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTCID: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company") today announce that it has changed its auditor... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,400 | +2,56 % | MustGrow Biologics Corp.: MustGrow Announces Grant of RSUs and DSUs | Saskatoon, Saskatchewan--(Newsfile Corp. - September 26, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced that the board of directors... ► Artikel lesen | |
| TVARDI THERAPEUTICS | 4,260 | +0,19 % | Tvardi Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| REVIVE THERAPEUTICS | 0,012 | 0,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement | TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing... ► Artikel lesen | |
| CYBIN | 5,400 | +0,93 % | Cybin gibt Update zur Neuropsychiatrie-Plattform und bevorstehenden klinischen Meilensteinen | - Erfolgreich abgeschlossene Aufnahme von 36 Teilnehmern in die Phase-2-Studie zu CYB004, dem DMT-Programm (deuteriertes Dimethyltryptamin, "DMT") des Unternehmens zur
Behandlung der... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 3,380 | +0,30 % | Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results | SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop... ► Artikel lesen | |
| LOBE SCIENCES | 0,020 | -6,98 % | Lobe Sciences Ltd.: Lobe Sciences Completes Debt Settlement to Improve Balance Sheet | VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies... ► Artikel lesen | |
| NUVALENT | 93,39 | +2,75 % | Nuvalent, Inc.: Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results | Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of... ► Artikel lesen |